“Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and Or BCL-2 Inhibitor Failure”. 2024. Canadian Hematology Today 3 (2): 49–53. https://doi.org/10.58931/cht.2024.3255.